Lifesciences@Work : We help scientists build their business


New drug targets and drugs for treating heart diseases are being discovered.

Toxic effects on the heart have frequently prompted the removal of drugs from the market, highlighting the need for better assays to reliably screen for these toxic effects at a preclinical stage. Human stem cell technology provides a reproducible source of functional human heart muscle cells.

Based on a combination of these human heart cells and the company’s proprietary Cytostretch dynamic heart platform, different assays for drug toxicity screening, as well as cardiac disease models, are being developed.